These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1847783)
1. Inhibition of allergic bronchoconstriction in asthmatics by the leukotriene-antagonist ICI-204,219. Dahlén SE; Dahlén B; Eliasson E; Johansson H; Björck T; Kumlin M; Boo K; Whitney J; Binks S; King B Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():461-4. PubMed ID: 1847783 [No Abstract] [Full Text] [Related]
2. Formation of PGD2 after allergen inhalation in atopic asthmatics. Sladek K; Sheller JR; FitzGerald GA; Morrow JD; Roberts LJ Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():433-6. PubMed ID: 1847781 [No Abstract] [Full Text] [Related]
3. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction. O'Shaughnessy KM; Taylor IK; O'Connor B; O'Connell F; Thomson H; Dollery CT Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105 [TBL] [Abstract][Full Text] [Related]
4. Further evidence that leukotrienes are the major mediators of allergic constriction in human bronchi. Björck T; Harada Y; Dahlén B; Zetterström O; Johansson G; Rodriguez L; Hedqvist P; Dahlén SE Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():429-32. PubMed ID: 1825576 [No Abstract] [Full Text] [Related]
5. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824 [TBL] [Abstract][Full Text] [Related]
6. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. Dahlén B; Zetterström O; Björck T; Dahlén SE Eur Respir J; 1994 Feb; 7(2):324-31. PubMed ID: 8162986 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219. Smith LJ; Glass M; Minkwitz MC Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486 [TBL] [Abstract][Full Text] [Related]
8. Comparative contractile responses to sulfidopeptide leukotrienes in normal and asthmatic human subjects. Drazen JM Ann N Y Acad Sci; 1988; 524():289-97. PubMed ID: 2837964 [No Abstract] [Full Text] [Related]
9. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219. Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. O'Shaughnessy KM; Wellings R; Gillies B; Fuller RW Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1472-6. PubMed ID: 8389108 [TBL] [Abstract][Full Text] [Related]
12. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma. Findlay SR; Barden JM; Easley CB; Glass M J Allergy Clin Immunol; 1992 May; 89(5):1040-5. PubMed ID: 1583246 [TBL] [Abstract][Full Text] [Related]
13. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Christie PE; Tagari P; Ford-Hutchinson AW; Black C; Markendorf A; Schmitz-Schumann M; Lee TH Am Rev Respir Dis; 1992 Dec; 146(6):1531-4. PubMed ID: 1333741 [TBL] [Abstract][Full Text] [Related]
14. Specific allergen induces contraction of bronchi and formation of leukotrienes C4, D4, and E4 in human asthmatic lung. Hansson G; Björck T; Dahlén SE; Hedqvist P; Granström E; Dahlén B Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():153-9. PubMed ID: 6303083 [No Abstract] [Full Text] [Related]
15. Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with bronchial asthma. Nathan RA; Glass M; Minkwitz MC Chest; 1994 Feb; 105(2):483-8. PubMed ID: 8306751 [TBL] [Abstract][Full Text] [Related]
16. Bronchial challenge to house dust can induce immediate bronchoconstriction in allergic asthmatic patients. M'Raihi L; Charpin D; Thibaudon M; Vervloet D Ann Allergy; 1990 Dec; 65(6):485-8. PubMed ID: 2256579 [TBL] [Abstract][Full Text] [Related]
17. Urinary leukotriene E4 in bronchial asthma. Smith CM; Hawksworth RJ; Thien FC; Christie PE; Lee TH Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055 [TBL] [Abstract][Full Text] [Related]
18. Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction. Frølund L; Madsen F; Nielsen J Allergy; 1991 Jul; 46(5):355-61. PubMed ID: 1928658 [TBL] [Abstract][Full Text] [Related]
19. Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Hui KP; Barnes NC Lancet; 1991 May; 337(8749):1062-3. PubMed ID: 1673495 [TBL] [Abstract][Full Text] [Related]
20. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Christie PE; Tagari P; Ford-Hutchinson AW; Charlesson S; Chee P; Arm JP; Lee TH Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1025-9. PubMed ID: 1850964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]